热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-human CD3 Antibody
产品名称：
Purified anti-human CD3 Antibody
产品类别：
抗体
产品编号：
317301
产品应用：
317301
[价格]
规格 价格 库存
25µg ￥ 30 1

产品详情

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC-F - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The OKT3 monoclonal antibody reacts with an epitope on the epsilon-subunit within the human CD3 complex.

Clone OKT3 can block the binding of clones SK7 and UCHT1.4 The OKT3 antibody is able to induce T cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections and activation of T cells. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 317304). For highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 317326) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin <0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
  3. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
  4. Li B, et al. 2005. Immunology 116:487.
  5. Jeong HY, et al. 2008. J. Leuckocyte Biol. 83:755. PubMed
  6. Alter G, et al. 2008. J. Virol. 82:9668. PubMed
  7. Manevich-Mendelson E, et al. 2009. Blood 114:2344. PubMed
  8. Pinto JP, et al. 2010. Immunology. 130:217. PubMed
  9. Biggs MJ, et al. 2011. J. R. Soc. Interface. 8:1462. PubMed
Product Citations
  1. Mousset CM, et al. 2018. Oncoimmunology. 7:e1488565. PubMed
  2. Jeong H, et al. 2008. J Leukoc Biol. 83:755. PubMed
  3. Biggs M, et al. 2011. J R Soc Interface. 1.348611111. PubMed
  4. Mammadli M, et al. 2021. Clin Transl Med. 11:e625. PubMed
  5. Blas-Rus N, et al. 2016. Nat Commun. 7: 11389. PubMed
  6. Mehta N, et al. 2020. Sci Rep. 10:15171. PubMed
  7. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
  8. Li G, et al. 2021. Oncoimmunology. 10:1983306. PubMed
  9. Weinhage T, et al. 2020. J Immunol. 205:56. PubMed
  10. Berkson JD, et al. 2020. Immunohorizons. 4:14. PubMed
  11. Barzilai S, et al. 2017. Cell Rep. 18(3):685-699. PubMed
  12. Bae EA, et al. 2018. Cancer Res. 78:5315. PubMed
  13. Liang J, et al. 2017. Nat Commun. 8:15732. PubMed
  14. Ghosh S, et al. 2020. Cell Reports. 30(10):3434-3447. PubMed
  15. Willing A, et al. 2018. J Immunol. 200:974. PubMed
  16. Bluhm J, et al. 2018. Mol Ther. 26:1906. PubMed
  17. Yarzabek B et al. 2018. eLife. 7 pii: e34961. PubMed
  18. Lang C, Wang J, and Chen L 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.09.030. PubMed
  19. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  20. Amiad-Pavlov D, et al. 2021. Sci Adv. 7: . PubMed
  21. Nissim L et al. 2017. Cell. 171(5):1138-1150 . PubMed
  22. García–Ortiz A, et al. 2017. PLoS Biol. 15:e2000653. PubMed
  23. Kujawski M, et al. 2019. BMC Cancer. 1.404166667. PubMed
  24. Willimsky G, et al. 2021. Elife. 10:. PubMed
  25. Mann ER, et al. 2020. Sci Immunol. :5. PubMed
  26. Nathan A, et al. 2021. Cell. 184(17):4401-4413.e10. PubMed
  27. Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
  28. Holbrook AK, et al. 2019. Physiol Rep. 7:e14234. PubMed
  29. Winkler M, et al. 2017. PLoS One.. 10.1371/journal.pone.0182427. PubMed
  30. Dilchert J, et al. 2022. Antibodies (Basel). 11:. PubMed
  31. Alcántara-Hernández M, et al. 2021. Nat Protoc. 16:4855. PubMed
  32. Xiong Y, et al. 2019. J Immunol. 203:3023. PubMed
  33. Kessel C, et al. 2017. Arthritis Rheumatol. 69:1480. PubMed
  34. Fu Z, et al. 2021. Acta Pharm Sin B. 11:3925. PubMed
  35. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  36. Jilg N, et al. 2020. J Infect Dis. 222:1837. PubMed
  37. Hu X, et al. 2021. British Journal of Pharmacology. 178(6):1445-1458. PubMed
  38. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  39. Li L, et al. 2020. J Transl Med. 18:363. PubMed
  40. Broos K, et al. 2019. Cancers (Basel). 11. PubMed
  41. Zhao R, et al. 2018. Oncoimmunology. 8:e1509173. PubMed
  42. Li H, et al. 2020. Front Immunol. 11:1777. PubMed
  43. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  44. Walk J, et al. 2020. Front Immunol. 2.405555556. PubMed
  45. Johnston HE, et al. 2018. Mol Cell Proteomics. 1.247222222. PubMed
  46. Thomi R, et al. 2017. Br J Dermatol.. 10.1111/bjd.15458. PubMed
  47. Kim G, et al. 2021. J Infect Dis. 224:1861. PubMed
  48. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  49. Mayer KE, et al. 2019. Theranostics. 4.548611111. PubMed
  50. Tripathi T, et al. 2019. Immunohorizons. 0.201388889. PubMed
  51. Alter G, et al. 2008. J Virol. 82:9668. PubMed
  52. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
  53. Zu?iga J, et al. 2020. Int J Infect Dis. 94:4. PubMed
  54. Wang Q, et al. 2020. J Immunother Cancer. 8:. PubMed
  55. Glud EN, et al. 2022. Br J Cancer. Online ahead of print. PubMed
  56. Pinto J, et al. 2010. Immunology. 130:217. PubMed
  57. Auladell M, et al. 2019. Clin Transl Immunology. 8:e01090. PubMed
  58. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  59. Qiu H, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.08.036. PubMed
  60. Jin Y, et al. 2017. Int Immunopharmacol. . 10.1016/j.intimp.2017.10.009. PubMed
  61. Schoknecht T, et al. 2017. J Leukoc Biol. 101:589. PubMed
  62. Escudero–Pérez B, et al. 2019. JCI Insight. 4:e126070. PubMed
  63. Guo J, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Wiedeman AE, et al. 2020. J Clin Invest. 130:480. PubMed
  65. Rivera-Cruz CM, et al. 2022. Cytotherapy. Online ahead of print. PubMed
  66. Park S, et al. 2020. Biosens Bioelectron. 112389:165. PubMed
  67. Henrick BM, et al. 2021. Cell. . PubMed
  68. Zavidij O, et al. 2020. Nat Cancer. 0.384027778. PubMed
  69. Manevich-Mendelson E, et al. 2009. Blood. 114:2344. PubMed
  70. Caielli S, et al. 2019. Nat Med. 25:75. PubMed
  71. Ardain A, et al. 2019. Nature. 570:528. PubMed
  72. Horn LA, et al. 2017. Oncotarget. 8:57964. PubMed
  73. Singh AK, et al. 2017. Front Immunol. 0.513888889. PubMed
  74. Lee YS, et al. 2021. J Immunother Cancer. 9:. PubMed
  75. Bacot SM, et al. 2020. Int J Mol Sci. 21:. PubMed
  76. Hirama T, et al. 2021. JCI Insight. 6:. PubMed
  77. Levin SD, et al. 2020. Front Immunol. 10:3086. PubMed
  78. Pawlak EN, et al. 2018. Retrovirology. 15:6. PubMed
  79. Meng Q, et al. 2018. Sci Rep. 8:17079. PubMed
  80. Boutboul D, et al. 2018. J Clin Invest. 128:3071. PubMed
  81. Chevalier MF, et al. 2017. J Clin Invest. 127:2916. PubMed
  82. Carriche GM, et al. 2021. J Allergy Clin Immunol. 147:335. PubMed
  83. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  84. Benabdallah B, et al. 2019. Front Immunol. 10:2580. PubMed
  85. Sneddon S, et al. 2020. Oncoimmunology. 9:1684713. PubMed
  86. Moosmann C, et al. 2022. STAR Protoc. 3:101031. PubMed
  87. Cassioli C, et al. 2021. Front Cell Dev Biol. 9:673446. PubMed
  88. Müller TR, et al. 2021. Cell Rep Med. 2:100374. PubMed
  89. Crome SQ, et al. 2017. Nat Med. 1.213888889. PubMed
  90. Hashimoto M, et al. 2017. Int J Inflam. 2017:1324735. PubMed
  91. Siegers GM, et al. 2020. Front Immunol. 1.352083333. PubMed
  92. Garcia de Moura R, et al. 2021. Front Immunol. 12:632667. PubMed
  93. Naranbhai V, et al. 2022. Cell. . PubMed
  94. Yang J, et al. 2020. Nat Commun. 11:4402. PubMed
  95. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  96. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  97. He Y, et al. 2021. eLife. 10:00. PubMed
  98. Yin Y, et al. 2017. J Allergy Clin Immunol. 139:1701. PubMed
  99. Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed
  100. Liu Z, et al. 2017. Oncotarget. 8:53518. PubMed
  101. Terzuoli E, et al. 2019. Cancers (Basel). 1.821527778. PubMed
  102. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  103. Welch JL, et al. 2020. FEBS Lett. 594:695. PubMed
  104. Leylek R, et al. 2020. Cell Rep. 32:108180. PubMed
  105. Dutertre CA, et al. 2020. Immunity. 51(3):573-589.e8.. PubMed
  106. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  107. Shalata W, et al. 2021. Cancers (Basel). 13: . PubMed
RRID
AB_571926 (BioLegend Cat. No. 317301) AB_571927 (BioLegend Cat. No. 317302)

Antigen Details

Structure
Ig superfamily, the subunits CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) form the CD3/TCR complex, 20 kD
Distribution

Mature T and NK T cells, thymocyte differentiation

Function
Antigen recognition, signal transduction, T cell activation
Ligand/Receptor
Peptide antigen bound to MHC
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References
  1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
  2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
  3. Lanier L, et al. 1986. J. Immunol. 137:2501.
Gene ID
916 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线